Results 81 to 90 of about 11,965 (231)

Restoration of a Stuck Leaflet

open access: yesCatheterization and Cardiovascular Interventions, Volume 106, Issue 1, Page 527-529, July 1, 2025.
ABSTRACT Severe aortic regurgitation (AR) for a leaflet malfunction after transcatheter aortic valve implantation (TAVI) is a dreadful complication that can lead even to cardiogenic shock. New valve's design has reduced the rate of paravalvular regurgitation, however central regurgitation is still a challenging complication.
Elisa Tomarelli   +3 more
wiley   +1 more source

Tratamento cirúrgico das valvopatias aórticas com bioprótese de pericárdio bovino sem suporte: resultados imediatos Surgical treatment of aortic valve disease with stentless bovine pericardium prosthesis: immediate results

open access: yesArquivos Brasileiros de Cardiologia, 2006
OBJETIVO: Apresentar os resultados imediatos e avaliar o desempenho clínico e hemodinâmico das biopróteses sem suporte de pericárdio bovino (stentless) em posição aórtica.
Wesley Ferreira de Araújo   +6 more
doaj   +1 more source

Very Early and Unusual Aortic Bioprosthetic Valve Deterioration 9 Months after Implantation

open access: yesJournal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2020
Every component of valvular bioprostheses is prone to variable structural deterioration secondary to multifactorial etiopathogenesis. Calcific degeneration is the most common phenomenon.
Madhu Shukla   +2 more
doaj   +1 more source

Contemporary outcomes after surgical aortic valve replacement with bioprostheses and allografts: ßA systematic review and meta-analysis [PDF]

open access: yes, 2016
Many observational studies have reported outcomes after surgical aortic valve replacement (AVR), but there are no recent systematic reviews and meta-analyses including all available bioprostheses and allografts.
Bekkers, J.A. (Jos)   +6 more
core   +1 more source

Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
Background Bioprosthetic heart valves (BHVs), fabricated from glutaraldehyde‐pretreated bovine pericardium or porcine aortic valves, are widely used for the surgical or interventional treatment of heart valve disease.
Suengwon Lee   +8 more
doaj   +1 more source

Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design [PDF]

open access: yes, 2017
OBJECTIVES The aim was to investigate the safety and feasibility of the redesigned Engager™ transcatheter aortic valve implantation (TAVI) system.
Bleiziffer, Sabine   +7 more
core   +1 more source

Reticulação progressiva de pericárdio bovino com glutaraldeído para confecção de válvulas cardíacas biológicas The progressive crosslinking of collagen matrices with glutaraldehyde in the manufacture of biological cardiac valves

open access: yesPolímeros, 1998
Este trabalho descreve um novo processo para a reticulação de matrizes de colágeno com glutaraldeído para a preparação de materiais para a confecção de válvulas cardíacas biológicas, e consiste no tratamento do pericárdio bovino com concentrações ...
Gilberto Goissis   +4 more
doaj   +1 more source

Repair of ascending aorta pseudoaneurysm without circulatory arrest in redo patient [PDF]

open access: yes, 2006
A pseudoaneurysm of the ascending aorta is an unusual and potentially fatal complication after aortic surgical operations. TEE and CT scan are the investigations of choice. Surgical treatment is mandatory.
Auriemma Stefano   +4 more
core   +2 more sources

Thrombosis of Bioprosthetic Aortic Valve: Is the Entire Arsenal Deployed?

open access: yesReviews in Cardiovascular Medicine
The proliferation of transcatheter aortic valve implantation has alerted clinicians to a specific type of prosthetic degeneration represented by thrombosis. The pathogenesis of this clinical or subclinical phenomenon, which can occur in up to 15% of both
Claudia Maria Loardi   +5 more
doaj   +1 more source

SOURCE 3 Registry Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve [PDF]

open access: yes, 2017
BACKGROUND: The SOURCE 3 Registry (SAPIEN Aortic Bioprosthesis European Outcome) is a European multicenter, observational registry of the latest generation of transcatheter heart valve, the SAPIEN 3 (Edwards Lifesciences, Irvine, CA).
Baumgartner, Helmut   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy